KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Short-term Investments (2016 - 2025)

Pfizer (PFE) has disclosed Short-term Investments for 16 consecutive years, with $13.6 billion as the latest value for Q3 2025.

  • On a quarterly basis, Short-term Investments changed N/A to $13.6 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $13.6 billion, a N/A change, with the full-year FY2024 number at $19.4 billion, up 97.56% from a year prior.
  • Short-term Investments was $13.6 billion for Q3 2025 at Pfizer, down from $19.4 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $29.1 billion in Q4 2021 to a low of $6.0 billion in Q2 2024.
  • A 4-year average of $15.0 billion and a median of $12.8 billion in 2021 define the central range for Short-term Investments.
  • Biggest YoY gain for Short-term Investments was 97.56% in 2024; the steepest drop was 97.56% in 2024.
  • Pfizer's Short-term Investments stood at $29.1 billion in 2021, then crashed by 66.22% to $9.8 billion in 2023, then surged by 97.56% to $19.4 billion in 2024, then fell by 29.81% to $13.6 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Short-term Investments are $13.6 billion (Q3 2025), $19.4 billion (Q4 2024), and $6.0 billion (Q2 2024).